Clinical Trial Details

AZA-MDS-006 (Connect)

Connect@ MDS/AML Disease Registry

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Leukemia
Study Type: Non-Interventional
Phase: N/A
Study Start Date: 11/20/14
Study Completion Date: 12/2018

The purpose of the Connect® MDS/AML Disease Registry is to provide unique insights into treatment regimens and sequencing of these regimens as they relate to clinical outcomes of patients with newly diagnosed MDS, ICUS or AML in routine clinical practice and evaluate molecular and cellular markers that may provide further prognostic classification and/or might be predictive of therapy outcomes.

NCT Number

NCT01688011

Principal Investigator(s)

Mohit Narang, MD

Sponsor(s)

Celgene

Participant Eligibility

• Age: 18 - No Maximum
• Gender: Male, Female